Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Gusstoon Apr 16, 2018 3:54pm
186 Views
Post# 27893219

RE:RE:RE:RE:RE:My questrade is showing the share price is at 0.24 cents

RE:RE:RE:RE:RE:My questrade is showing the share price is at 0.24 centsI agree on really bad timing on the news release, however I do not agree by a longshot that this stock is done, saying such on these boards just gets newbies to panic and sell making this selloff that much worse IMO.   
  it just needs to find a bottom and looking at market depth and technicals I would say its pretty damn close, we are heavily oversold and I am expecting a sweet reversal, just a matter of time. :)



Level ll Quote
  Bid     Ask
  Price   Total Size   # of Orders     Price   Total Size   # of Orders
$0.175 107500 3   $0.18 97000 5
$0.17 227000 13   $0.185 73500 7
$0.165 120000 6   $0.19 40000 5
$0.16 287000 14   $0.195 98000 6
$0.155 84000 7   $0.20 99500 10
$0.15 249500 15   $0.205 99500 5
$0.145 9000 3   $0.21 77500 6
$0.13 11000 2   $0.215 79000 3
$0.12 10000 1   $0.22 53000 3
$0.115 200000 1   $0.225 24000 3
 


Bullboard Posts